​
​

Renalytix (RNLX) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

Renalytix Revenue Highlights

Latest Revenue (Y)

$2.29M

Latest Revenue (Q)

$724.00K

Main Segment (Y)

Licensed Products

Main Geography (Y)

Fractal Dx

Renalytix Revenue by Period

Renalytix Revenue by Year

DateRevenueChange
2024-06-30$2.29M-32.74%
2023-06-30$3.40M14.58%
2022-06-30$2.97M99.20%
2021-06-30$1.49M100.00%
2020-06-30-100.00%
2019-06-30-100.00%
2018-06-30--

Renalytix generated $2.29M in revenue during NA 2024, up -32.74% compared to the previous quarter, and up Infinity% compared to the same period a year ago.

Renalytix Revenue by Quarter

DateRevenueChange
2024-03-31$724.00K2.12%
2023-12-31$709.00K54.47%
2023-09-30$459.00K-11.39%
2023-06-30$518.00K-28.45%
2023-03-31$724.00K-39.26%
2022-12-31$1.19M23.01%
2022-09-30$969.00K16.61%
2022-06-30$831.00K2.34%
2022-03-31$812.00K-3.91%
2021-12-31$845.00K75.31%
2021-09-30$482.00K2.12%
2021-06-30$472.00K-23.75%
2021-03-31$619.00K54.75%
2020-12-31$400.00K-35.38%
2020-09-30$619.00K100.00%
2020-06-30-100.00%
2020-03-31-100.00%
2019-12-31-100.00%
2019-09-30-100.00%
2018-06-30--

Renalytix generated $724.00K in revenue during Q3 2024, up 2.12% compared to the previous quarter, and up 60.74% compared to the same period a year ago.

Renalytix Revenue Breakdown

Renalytix Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceJun 24Jun 23Jun 22Jun 21
Licensed Products$10.00M$10.00M$12.00M$10.00M
Fractal Dx--$300.00M$250.00M

Renalytix's latest annual revenue breakdown by segment (product or service), as of Jun 24: Licensed Products (100.00%).

Quarterly Revenue by Product

Product/ServiceJun 24Mar 24Dec 23
Licensed Products-$10.00M$10.00M

Renalytix Revenue Breakdown by Country

Annual Revenue by Country

CountryJun 22Jun 21
Fractal Dx$250.00M$250.00M
Licensed Products$10.00M$10.00M

Renalytix's latest annual revenue breakdown by geography, as of Jun 22: Fractal Dx (96.15%), and Licensed Products (3.85%).

Renalytix Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
PGNYProgyny$1.09B$286.63M
HQYHealthEquity$999.59M$299.93M
CPSITruBridge$326.65M$82.71M
HCATHealth Catalyst$295.94M$76.35M
HSTMHealthStream$279.06M$73.09M
NRCNational Research$148.58M$35.82M
SNCEScience 37$70.15M$14.89M
AUGXAugmedix$44.85M$13.66M
STRMStreamline Health Solutions$22.60M$4.48B
FORAForian$20.48M$4.78M
RNLXRenalytix$2.29M$724.00K
AKLIAkili$1.68M$383.00K
MGRXMangoceuticals-$162.56K

RNLX Revenue FAQ

What is Renalytix’s yearly revenue?

Renalytix's yearly revenue for 2024 was $2.29M, representing a decrease of -32.74% compared to 2023. The company's yearly revenue for 2023 was $3.4M, representing an increase of 14.58% compared to 2022. RNLX's yearly revenue for 2022 was $2.97M, representing an increase of 99.20% compared to 2021.

What is Renalytix’s quarterly revenue?

Renalytix's quarterly revenue for Q3 2024 was $724K, a 2.12% increase from the previous quarter (Q2 2024), and a 0% increase year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $709K, a 54.47% increase from the previous quarter (Q1 2024), and a -40.52% decrease year-over-year (Q2 2023). RNLX's quarterly revenue for Q1 2024 was $459K, a -11.39% decrease from the previous quarter (Q4 2023), and a -52.63% decrease year-over-year (Q1 2023).

What is Renalytix’s revenue growth rate?

Renalytix's revenue growth rate for the last 3 years (2022-2024) was -22.93%, and for the last 5 years (2020-2024) was 0%.

What are Renalytix’s revenue streams?

Renalytix's revenue streams in n 24 are Licensed Products

What is Renalytix’s main source of revenue?

For the fiscal year ending Jun 24, the largest source of revenue of Renalytix was Licensed Products. This segment made a revenue of $10M, representing 100.00% of the company's total revenue.